title: Can we justify living donor islet transplantation?
authors.affiliation: Cardiovascular, Metabolic Diseases, Pfizer Inc., Groton, CT 06340, USA. Boaz.Hirshberg@pfizer.com
authors.forename: Boaz
authors.initials: B
authors.lastname: Hirshberg
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D016381:Islets of Langerhans Transplantation / Q000941:ethics*; D019520:Living Donors / Q000941:ethics*